Upstream Bio, Inc.

UPB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$33,748-$39,966-$27,270-$21,242
Dep. & Amort.-$2,828$42$43$49
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,594$2,597$2,635$2,086
Change in WC$16,037-$1,065-$14,972-$1,318
Other Non-Cash-$4,295-$847-$1,601$813
Operating Cash Flow-$22,240-$39,239-$41,165-$19,612
Investing Activities
PP&E Inv.$47-$47$0-$185
Net Acquisitions$0$0$0$0
Inv. Purchases-$24,458-$57,082-$266,056-$42,209
Inv. Sales/Matur.$72,708$69,902$52,675$84,302
Other Inv. Act.-$111$0$0$0
Investing Cash Flow$48,186$12,773-$213,381$41,908
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$578$612-$34$270,648
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$760$0$0$0
Financing Cash Flow$760$612-$34$270,648
Forex Effect$0$0$0$0
Net Chg. in Cash$26,706-$25,854-$254,580$292,944
Supplemental Information
Beg. Cash$45,652$71,506$326,086$33,142
End Cash$72,358$45,652$71,506$326,086
Free Cash Flow-$22,193-$39,286-$41,165-$19,797
Upstream Bio, Inc. (UPB) Financial Statements & Key Stats | AlphaPilot